Radiation Therapy News and Research

RSS
Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.
New biomarkers could lead to personalized radiation treatments for cancer patients

New biomarkers could lead to personalized radiation treatments for cancer patients

FDA clears DFine's new percutaneous radiofrequency ablation device for metastatic spinal lesions

FDA clears DFine's new percutaneous radiofrequency ablation device for metastatic spinal lesions

FDA provides Celsion guidance for Thermodox NDA to treat primary liver cancer

FDA provides Celsion guidance for Thermodox NDA to treat primary liver cancer

Elekta releases Atlas-based Autosegmentation 2.0 software for increasing contouring accuracy

Elekta releases Atlas-based Autosegmentation 2.0 software for increasing contouring accuracy

DMC recommends continuation of enrollment in Celsion's Phase III ThermoDox HEAT study for primary liver cancer

DMC recommends continuation of enrollment in Celsion's Phase III ThermoDox HEAT study for primary liver cancer

Ontario Breast Screening Program encourages women to get mammograms

Ontario Breast Screening Program encourages women to get mammograms

BSD receives patent for heat therapy applicators

BSD receives patent for heat therapy applicators

SCT transplantation benefits in Hodgkin's lymphoma is unclear

SCT transplantation benefits in Hodgkin's lymphoma is unclear

IsoRay reports increase revenue for 2010 fiscal year

IsoRay reports increase revenue for 2010 fiscal year

Clinical study results for patient-specific vaccine therapy to treat metastatic melanoma announced

Clinical study results for patient-specific vaccine therapy to treat metastatic melanoma announced

Researchers find radical prostatectomy provides high survival rates

Researchers find radical prostatectomy provides high survival rates

Premier Purchasing Partners announces new agreements for radiation oncology portfolio

Premier Purchasing Partners announces new agreements for radiation oncology portfolio

Rockland receives Phase I SBIR grant to develop assay for monitoring Akt pathway activity

Rockland receives Phase I SBIR grant to develop assay for monitoring Akt pathway activity

Breast cancer survivors with functional limitations more likely to die of poorer health: Study

Breast cancer survivors with functional limitations more likely to die of poorer health: Study

OncoGenex initiates OGX-427 Phase 2 trial for metastatic prostate cancer

OncoGenex initiates OGX-427 Phase 2 trial for metastatic prostate cancer

Signaling pathway inhibition enhances autologous bone marrow transplant: Research

Signaling pathway inhibition enhances autologous bone marrow transplant: Research

New federal funds to create first national patient registry for pulmonary fibrosis

New federal funds to create first national patient registry for pulmonary fibrosis

Cianna Medical launches SAVI Sisters program to educate about breast cancer treatment options

Cianna Medical launches SAVI Sisters program to educate about breast cancer treatment options

Revolutionary technology 'cooks' brain tumor

Revolutionary technology 'cooks' brain tumor

Impact of cancer treatment on cardiovascular function

Impact of cancer treatment on cardiovascular function

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.